Health Canada
- Status: approved
efavirenz, stavudine extended release, lamivudine (efavirenz, stavudine extended release, lamivudine) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.